RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
29.60
-0.73 (-2.41%)
Feb 21, 2025, 4:00 PM EST - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $1.19 billion as of February 21, 2025. Its market cap has decreased by -28.76% in one year.
Market Cap
1.19B
Enterprise Value
967.20M
1-Year Change
-28.76%
Ranking
Category
Stock Price
$29.60
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $1.19B, an increase of 181.15%. That is a compound annual growth rate of 33.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 1.22B | -11.78% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |